Literature DB >> 8019468

Influenza A virus infections among hospitalized adult bone marrow transplant recipients.

E Whimbey1, L S Elting, R B Couch, W Lo, L Williams, R E Champlin, G P Bodey.   

Abstract

Although influenza virus continues to cause annual epidemics of respiratory diseases, surprisingly little is known about the frequency and clinical course of influenza among adult patients with cancer. During the 1991-92 influenza epidemic in Houston, Texas, we followed all adult BMT recipients hospitalized at M.D. Anderson Cancer Center. None of these 68 patients had received prophylaxis for influenza. Influenza virus type A was isolated from 8 (29%) of 28 BMT recipients with an acute respiratory illness. Five of these infections were acquired in the hospital. All 8 patients presented with an upper respiratory tract illness. In 6 patients, the infection was complicated by pneumonia. The frequency of influenza was similar among autologous (5 of 18) and allogeneic (3 of 10) BMT recipients. The risk of developing pneumonia was not related to the type of transplant or to the engraftment status. All patients received broad-spectrum antibiotics. The 2 patients who did not develop pneumonia also received amantadine. The mortality with pneumonia was 17%. During community outbreaks, influenza is a frequent cause of acute respiratory illness among hospitalized adult BMT recipients and is frequently complicated by pneumonia. Studies are needed to define the optimal means of preventing and treating influenza in BMT recipients.

Entities:  

Mesh:

Year:  1994        PMID: 8019468

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  39 in total

1.  SimulFluor respiratory screen for rapid detection of multiple respiratory viruses in clinical specimens by immunofluorescence staining.

Authors:  M L Landry; D Ferguson
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus.

Authors:  Alexandre A Boudreault; Hu Xie; Wendy Leisenring; Janet Englund; Lawrence Corey; Michael Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2010-09-24       Impact factor: 5.742

Review 3.  Nosocomial spread of viral disease.

Authors:  C Aitken; D J Jeffries
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

Review 4.  Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses.

Authors:  Ken M Kunisaki; Edward N Janoff
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

Review 5.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

6.  Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies.

Authors:  Rodrigo Martino; Rocío Parody Porras; Nuria Rabella; John V Williams; Elena Rámila; Nuria Margall; Rosa Labeaga; James E Crowe; Pedro Coll; Jorge Sierra
Journal:  Biol Blood Marrow Transplant       Date:  2005-10       Impact factor: 5.742

Review 7.  Current research on influenza and other respiratory viruses: II international symposium.

Authors:  F M Munoz; G J Galasso; J M Gwaltney; F G Hayden; B Murphy; R Webster; P Wright; R B Couch
Journal:  Antiviral Res       Date:  2000-05       Impact factor: 5.970

8.  Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancer.

Authors:  Yiqing Xu; Nanda Methuku; Praveena Coimbatore; Theresa Fitzgerald; Yiwu Huang; Ying-Yi Xiao; Murali Pagala; Shachi Gupta; William Solomon; Philip Rubin; John Treanor; Alan Astrow; Howard Minkoff; Jay S Cooper
Journal:  Oncologist       Date:  2012-01-12

9.  Vaccination regimens incorporating CpG-containing oligodeoxynucleotides and IL-2 generate antigen-specific antitumor immunity from T-cell populations undergoing homeostatic peripheral expansion after BMT.

Authors:  James N Kochenderfer; Jessica L Simpson; Christopher D Chien; Ronald E Gress
Journal:  Blood       Date:  2007-03-19       Impact factor: 22.113

Review 10.  How I treat influenza in patients with hematologic malignancies.

Authors:  Corey Casper; Janet Englund; Michael Boeckh
Journal:  Blood       Date:  2009-12-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.